Farestos 20 mg Pharmacom Labs
| Features | |
| Active substance | Toremifene Citrate |
| Also known as | FC 1157a, NK 622 |
| Blood pressure | Can cause fluctuations |
| Chemical name | (Z)-2-[4-[(1Z)-4-chloro-1,2-diphenylbut-1-en-1-yl]phenoxy]-N,N-dimethylethanamine citrate |
| Dosage (medical) | Typically 60 mg daily |
| Dosage (sports) | 10-60 mg daily |
| Effects | Blocks estrogen receptors, reduces the progression of estrogen-responsive cancers |
| Formula | C26H28ClNOВ·C6H8O7 |
| Half-life | Approximately 5 days |
| Hepatotoxicity | Low |
| Lab Test | Elevated liver enzymes might occur, requires monitoring |
| Main action | Anti-estrogen |
| Side effects | Hot flashes, sweating, nausea, dizziness, visual disturbances, increased risk of blood clots |
| Storage conditions | Store at room temperature away from moisture and heat |
| Substance class | Selective Estrogen Receptor Modulator (SERM) |
| Trade name | Fareston |
| Use in sports | Used to counteract side effects of anabolic steroids, mainly gynecomastia |
| Water Retention | No |
| Active ingredient, mg | 20 |
| Release form | Pills |
| 1 Pill, mg | 20 |
| Blister, pills | 2, 50 |
| Manufacturer | Pharmacom Labs |
| Packing | Blister (50 Pills), Packing (2 blisters) |